[0JBU] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -33.94%
YoY- -23.71%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Quarter Result
30/06/25 30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
Revenue 14,245 6,957 13,594 14,030 6,550 16,263 11,118 4.21%
PBT -101,255 -146,975 -123,681 -100,678 -68,806 -32,393 -25,683 25.66%
Tax 0 0 0 -703 0 0 0 -
NP -101,255 -146,975 -123,681 -99,975 -68,806 -32,393 -25,683 25.66%
Tax Rate - - - - - - - -
Total Cost 115,500 153,932 137,275 114,005 75,356 48,656 36,801 20.97%
Ratio Analysis
30/06/25 30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
NP Margin -710.81 -2,112.62 -909.82 -712.58 -1,050.47 -199.18 -231.00 20.58%
Per Share
30/06/25 30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 CAGR
EPS -0.98 -1.52 -1.40 -1.32 -1.01 -0.61 -0.56 9.76%
EPS Diluted -0.98 -1.52 -1.40 -1.32 -1.01 -0.61 -0.56 9.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.